Establishment of an induced pluripotent stem cell line from a patient with CHARGE syndrome carrying a CHD7 (p.L1151Gfs*17) mutation

被引:1
|
作者
He, Shouhuan [1 ]
Hu, Jintao [2 ,3 ]
Zheng, Zhong [4 ,5 ]
Wang, Jingjing [4 ,5 ]
Chen, Jianling [6 ]
Zhang, Cui [6 ]
Li, Liang [6 ]
Wang, Jiping [4 ,5 ]
Chen, Zhengnong [4 ,5 ]
Shi, Haibo [4 ,5 ,7 ]
Wang, Jinfu [6 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Otolaryngol, Shanghai 201700, Peoples R China
[2] Zhejiang Chinese Med Univ, Clin Med Coll 3, Hangzhou 310053, Peoples R China
[3] Hangzhou Xiaoshan Dist Chinese Med Hosp, Dept Orthoped, Hangzhou 311200, Peoples R China
[4] Shanghai Jiao Tong Univ, Dept Otolaryngol Head & Neck Surg, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China
[5] Shanghai Jiao Tong Univ, Otolaryngol Inst, Shanghai 200233, Peoples R China
[6] Zhejiang Univ, Coll Life Sci, Inst Cell Biol, Lab Stem Cells, Hangzhou 310058, Zhejiang, Peoples R China
[7] Shanghai Key Lab Sleep Disordered Breathing, Shanghai 200233, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.scr.2020.101774
中图分类号
Q813 [细胞工程];
学科分类号
摘要
CHARGE syndrome is a rare disease caused by a genetic disorder. The clinical features of this syndrome include coloboma of the eye, heart anomaly, choanal atresia, retardation of mental and somatic development, microphallus, ear abnormalities and/or deafness. CHD7 is the main causative gene for CHARGE syndrome. In this study, we generated an induced pluripotent stem cell (iPSC) line from the dermal fibroblasts of a 1.5 -year -old girl, carrying a de novo mutation ( CHD7 ;NM_017780;c.3449_3450delTC;p.L1151Gfs*17). This iPSC line will be a useful tool for investigating the pathogenesis and for developing treatment for this complicated syndrome.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Establishment of a human-induced pluripotent stem cell line from a long QT syndrome type 2 patient harboring a KCNH2 mutation
    Mun, Dasom
    Kang, Ji-Young
    Park, Malgeum
    Yoo, Gyeongseo
    Kim, Hyoeun
    Yun, Nuri
    Hwang, You Mi
    Joung, Boyoung
    STEM CELL RESEARCH, 2024, 81
  • [32] Generation of an induced pluripotent stem cell line from a Kennedy Disease patient with AR mutation
    Zhang, Meng
    Liu, Rui
    Sun, Pengpeng
    Zhang, Chengsen
    Wang, Jingdong
    Li, Changjiang
    STEM CELL RESEARCH, 2025, 83
  • [33] Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/ c.3764C>A mutation
    Sun, Yaxun
    Zhou, Jingjun
    Wang, Hongkun
    Wang, Hao
    Chen, Xianzhen
    Gong, Tingyu
    Liang, Ping
    Jiang, Chenyang
    STEM CELL RESEARCH, 2022, 64
  • [34] Establishment of an induced pluripotent stem(iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation
    Terray, Angelique
    Fort, Victoire
    Slembrouck, Amelie
    Nanteau, Celine
    Sahel, Jose-Alain
    Reichman, Sacha
    Audo, Isabelle
    Goureau, Olivier
    STEM CELL RESEARCH, 2017, 25 : 26 - 29
  • [35] Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia
    Marcatili, Matteo
    Marsoner, Fabio
    D'Agostino, Armando
    Karnavas, Thodoris
    Bottai, Daniele
    Scarone, Silvio
    Conti, Luciano
    STEM CELL RESEARCH, 2016, 17 (03) : 630 - 633
  • [36] Establishment of an induced pluripotent stem cell line (SHFDi001-A) from a patient with ankylosing spondylitis
    Hu, Jintao
    Lu, Chuanjia
    Zhu, Wenjing
    Jiang, Qun
    Du, Weibin
    Wu, Nan
    STEM CELL RESEARCH, 2020, 46
  • [37] Establishment of an induced pluripotent stem cell line (FDEENTi001-A) from a patient with pathological myopia
    Bai, Xinyue
    Yang, Xianjie
    Cheng, Yun
    Chen, Ling
    STEM CELL RESEARCH, 2019, 34
  • [38] Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene
    Hong, Junjie
    Xu, Miao
    Li, Rong
    Cheng, Yu-Shan
    Kouznetsova, Jennifer
    Beers, Jeanette
    Liu, Chengyu
    Zou, Jizhong
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 37
  • [39] Establishment of an induced pluripotent stem cell line from a Noonan syndrome patient with the heterozygote mutation p.S257L (c.770C > T) in RAF1 gene
    Guo, Xiaoling
    Qian, Rengcheng
    Yang, Liang
    Chen, Huihui
    Ding, Yinjuan
    Shan, Xiaoou
    Chen, Congde
    Ni, Wenfei
    Lin, Jian
    Chu, Maoping
    STEM CELL RESEARCH, 2021, 53
  • [40] Establishment of an induced pluripotent stem cell model of Hirschsrpung disease, a congenital condition of the enteric nervous system, from a patient carrying a novel RET mutation
    Wang, Yong
    Lai, Xingqiang
    Huang, Lihua
    Liu, Guangjian
    Zai, Zhicheng
    Zhu, Deli
    Zhang, Yan
    Liang, Zijian
    Yao, Zhiguang
    Chen, Yunpei
    Wen, Zhe
    Xia, Huimin
    NEUROREPORT, 2018, 29 (12) : 975 - 980